Abstract
Type I CRISPR-Cas3 uses an RNA-guided multi Cas-protein complex, Cascade, which detects and degrades foreign nucleic acids via the helicase-nuclease Cas3 protein. Despite many studies using cryoEM and smFRET, the precise mechanism of Cas3-mediated cleavage and degradation of target DNA remains elusive. Here we reconstitute the CRISPR-Cas3 system in vitro to show how the Escherichia coli Cas3 (EcoCas3) with EcoCascade exhibits collateral non-specific single-stranded DNA (ssDNA) cleavage and target specific DNA degradation. Partial binding of EcoCascade to target DNA with tolerated mismatches within the spacer sequence, but not the PAM, elicits collateral ssDNA cleavage activity of recruited EcoCas3. Conversely, stable binding with complete R-loop formation drives EcoCas3 to nick the non-target strand (NTS) in the bound DNA. Helicase-dependent unwinding then combines with trans ssDNA cleavage of the target strand and repetitive cis cleavage of the NTS to degrade the target double-stranded DNA (dsDNA) substrate. High-speed atomic force microscopy demonstrates that EcoCas3 bound to EcoCascade repeatedly reels and releases the target DNA, followed by target fragmentation. Together, these results provide a revised model for collateral ssDNA cleavage and target dsDNA degradation by CRISPR-Cas3, furthering understanding of type I CRISPR priming and interference and informing future genome editing tools.
Subject terms: CRISPR-Cas systems, CRISPR-Cas systems
In this study, Yoshimi et al. report on the mechanisms of CRISPR-Cas3 non-specific cleavage of single-stranded DNA and target-specific degradation of double stranded DNA. They employ high-speed AFM to capture images of type I CRISPR priming and interference.
Introduction
The clustered-regularly-interspaced-short-palindromic-repeats (CRISPR) CRISPR-associated proteins (Cas) system allows for adaptive immunity in prokaryotes. CRISPR protein complexes comprise two classes, with each class classified into three types where Class 1 includes types I, III, IV and Class 2 includes types II, V, and VI1. Class 1 systems use multiple different Cas proteins, while Class 2 effectors contain only a single protein. To date, much attention has focused on the mechanism of Class 2 effectors, such as type II Cas9, type V Cas12, and type VI Cas13, given their practical applications in genome editing and manipulation2–6. Type 1 systems are also now emerging as tools for genome and transcriptome manipulation in microbiota7,8 and eukaryotic cells9–11. Binding of type I CRISPR-Cas effectors to DNA sequences in the absence of Cas3 leads to transcriptional repression in bacteria7 and human cells9. For DNA editing, introduction of the Cascade multi Cas-protein complex, CRISPR RNA (crRNA), and the Cas3 helicase-nuclease into mammalian cells results in long-range chromosomal deletions in target DNA10,11. The long-range deletions generated by Cas3 contrasts with smaller deletions (or indels) generated by Cas9/Cas12 editing, and has led to the descriptions of DNA shredder and scissors, respectively.
Considerable efforts have been devoted to understanding the mechanism of CRISPR interference by type I CRISPR12–27. Several cryo-electron microscopy (EM) structures of type I CRISPR complexes have been solved, revealing seahorse-shaped structures containing Cas5, Cas6, multiple Cas7, Cas8 (Cse1), which recognizes the PAM, and two Cas11 (Cse2) (Fig. 1a). Type I CRISPR systems target homologous regions of double-stranded DNA (dsDNA) for degradation through two major steps: recognition of a target DNA by Cascade complex surveillance, and cleavage of the DNA by Cas3 that is recruited by the Cascade complex24–26. In the first step, the Cascade complex, including Cas8, scans the PAM (protospacer adjacent motif) and initiates DNA unwinding at the PAM28. Subsequently, crRNA hybridization with the target DNA strand (TS) leads to displacement of the non-target strand (NTS), forming a three-stranded nucleic acid structure known as an R-loop14–16,18,19,27. Complete formation of the R-loop induces a conformational change in the Cascade complex that enables recruitment of Cas315,19,29. The recruited Cas3, a protein with an SF2 (Superfamily 2) helicase domain and a HD (histidine-aspartate) nuclease domain, degrades the target DNA in a unidirectional ATP-dependent manner according to the following steps: nicking the NTS at the R-loop, loading onto the ssDNA, and unwinding the DNA while degrading the DNA13,15,26,30,31. Recently, single-molecule Förster resonance energy transfer (smFRET) experiments have shown that Cas3 can remain associated with Cascade to cleave ssDNA by a reeling mechanism12. However, Cas3 can also break free of Cascade and translocate on its own through the target DNA20. It is unclear whether Cas3 degrades DNA during independent translocation and how Cas3 with a single HD domain can degrade both the NTS and the TS of dsDNA32,33 (Fig. 1a).
This study reveals that the Escherichia coli Cascade crRNA complex (EcoCascade) assembled with E. coli Cas3 (EcoCas3) exhibits collateral trans-cleavage activity on a non-specific ssDNA. This promiscuous cleavage of collateral ssDNAs, named trans-cleavage, is distinguished from the programmable on-target cleavage of target ssDNA, namely, cis-cleavage34–36 (Fig. 1a). We show that unstable EcoCascade binding with partial R-loop formation with EcoCas3 mediates the collateral trans-cleavage, but does not lead to double-stranded DNA cleavage. In contrast, stable EcoCascade binding with locked R-loop construction provides cis-cleavage of the NTS with helicase-dependent trans separation and cleavage of the TS, resulting in progressive degradation of target dsDNA substrates. In vitro experiments using high-speed atomic force microscopy (hs-AFM) also demonstrate that EcoCas3 remains tightly associated with the EcoCascade, which repeatedly reels and releases the target DNA, followed by target degradation. These findings provide insight into the mechanism of type I CRISPR-Cas3 priming and interference against a foreign DNA.
Results
In vitro reconstitution of Escherichia coli CRISPR-Cas3 interference
E. coli CRISPR-Cas3 is generally well-characterized type I CRISPR complexes in vitro and in vivo32,33,37,38. However, recombinant EcoCas3 protein is difficult to purify because of poor solubility and propensity to aggregate at 37 °C25,26,30,39. Co-expression of HtpG chaperon40 and/or low temperature growth at 20 °C24,25 produced only a limited amount of protein that was highly aggregated (Supplementary Fig. 1a). This is in contrast to isolated Thermobifida fusca Cas3 (TfuCas3) protein produced by the E. coli bacterial expression system at 37 °C10,15,31 (Supplementary Fig. 1b). We then used Sf9 insect cells with a baculovirus expression system at 20 °C to produce EcoCas3 protein, which was soluble and ∼95% homogeneous (Supplementary Fig. 2a, b). EcoCascade proteins and crRNA were co-expressed in E. coli JM109(DE3) and purified using Ni-NTA resin as previously reported24,41 (Supplementary Fig. 2c, d). Tycho NT.6 protein stability measurements (Supplementary Fig. 3) and the ProteoStat protein aggregation assay (Supplementary Fig. 4) indicated that the temperature-dependent stability and aggregation onset temperature of EcoCas3 was consistent with a mesophilic protein25,26,30,39. Then, we confirmed co-purified recombinant EcoCascade-crRNA ribonucleoproteins (RNPs) bound to supercoiled (SC) plasmids composed of hEMX1 spacer sequences flanked by a PAM (5′-AAG-3′), but not bound to SC plasmids including spacer sequences flanked by a nonPAM (5′-CCA-3′) (Supplementary Fig. 5a). Binding of EcoCascade-crRNA RNPs was also observed for linear dsDNA molecules (mTyr and rIl2rg genes) (Supplementary Fig. 5b), and exchanging nucleotide pairs between crRNAs and target sequences abolished this binding (Supplementary Fig. 5c). Finally, assembly of EcoCascade RNPs with purified EcoCas3 protein specifically degraded SC plasmids (hEMX1) and linear dsDNA (mTyr) in the presence of ATP and Mg2+24,25,30,39,42 (Supplementary Fig. 6a, b).
The EcoCas3-EcoCascade-crRNA complex nonspecifically cleaves ssDNAs in trans
Cas3 proteins from Streptococcus thermophiles, Methanocaldococcus jannaschii, and Thermus thermophilus can exhibit indiscriminate, divalent cation-dependent ssDNase activity in the absence of Cascade30,39,42. Using fluorescent dye-quencher (FQ)-labeled ssDNA probes, we found that EcoCas3 and TfuCas3 also exhibit nonspecific ssDNA cleavage in a metal-dependent manner, although the dependency was different between the two bacteria (Fig. 1b). TfuCas3 cleaved ssDNA with all divalent ions tested, whereas EcoCas3 was only activated with Mn2+ and Ni2+, consistent with previous results25. Type V Cas12a, an RNA-guided DNase34, and type VI Cas13, an RNA-guided RNase43, engage in collateral cleavage of nearby non-specific nucleic acids after their targeted activity. To investigate whether Cas3 also possesses collateral ssDNA cleavage activity, we assembled EcoCas3, EcoCascade RNPs, 60 bp dsDNA fragments containing target sequences flanked by a PAM (targeted Activator), and a untargeted ssDNA44. We found that targeted degradation triggered untargeted degradation of both circular M13 phage ssDNA and linearized long ssDNA, but not of circular pBlueScript dsDNA (Supplementary Fig. 7a). As is the case with target dsDNA degradation by EcoCascade RNPs and EcoCas3 (Supplementary Fig. 6a, b), this collateral ssDNA cleavage was dependent upon the presence of a PAM in the targeted nucleic acid (Supplementary Fig. 7a). These results indicate that either some metal ions or Cascade target-binding by R-loop formation can induce EcoCas3-dependent non-specific ssDNA cleavage activity in vitro.
To quantitatively measure collateral ssDNA cleavage activity we used a FQ-labeled untargeted ssDNA probe34,43 (Fig. 1c), which is used in CRISPR-based diagnostics as a platform for rapid and sensitive nucleic acid detection, for example in Covid-19 test kits45–47. Consistent with the results of the M13/linear ssDNA cleavage (Supplementary Fig. 7a), EcoCas3 showed collateral ssDNA cleavage in a PAM-dependent manner (with a PAM of 5′-AAG-3′ or 5′-ATG-3′, but not 5′-CCA-3′) (Fig. 1c and Supplementary Fig. 7b, c). Fluorescent reporter DNA oligonucleotides (DNaseAlert™ IDT) also confirmed this collateral cleavage activity (Supplementary Fig. 8a), whereas fluorescent reporter RNA oligonucleotides (RNaseAlert™, IDT) detected little or no collateral RNase activity (Supplementary Fig. 8b). We previously showed that mutants of EcoCas3 in the HD domain (H74A, dead nuclease, dnCas3), and SF2 motif III (S483A/T485A, dead helicase, dhCas3) abolished target DNA degradation in human cells11. In the collateral cleavage assay, the dnCas3 mutant abolished all cleavage activity, but the dhCas3 mutant showed a similar level of activity as that of wild-type EcoCas3 (Fig. 1d). In ATP-free reaction buffer (−), the collateral activity of the EcoCas3 protein was at the same level or higher compared with that of wild-type EcoCas3 and the dhCas3 mutant in ATP (+) buffer (Fig. 1d). Together, these results indicate that trans cleavage of non-specific ssDNA is catalyzed by the single HD domain of EcoCas3 and that the helicase activity is not required for the trans cleavage but may restrain it.
PAM recognition is a prerequisite for collateral ssDNA cleavage by Cas3 but not Cas12a
Having determined that collateral ssDNA cleavage by the EcoCas3-EcoCascade complex is PAM-dependent (Fig. 1c), we sought to further characterize the specificity of PAM recognition by screening all 64 possible target sites containing each of the three-nucleotide PAM sequences (Fig. 2a and Supplementary Fig. 9a). We observed collateral cleavage activity with 14 PAM types, with the highest activity from 5′-AAG-3′ and 5′-ATG-3′, followed by 5′-GAG-3′, 5′-AAA-3′, 5′-AAC-3′, 5′-TAG-3′, and 5′-AGG-3′. There was no cleavage when the first or second PAM nucleotide was C or the third nucleotide was T (Fig. 2a and Supplementary Fig. 9a). This PAM recognition specificity for trans cleavage activity matched the results from an in vivo high-throughput CRISPR-interference assay48. In contrast, LbaCas12a showed collateral cleavage activity with almost all 64 PAM types, with the highest activity with 5′-GGGG-3′ and the lowest with 5′-GCCG-3′ (Fig. 2b and Supplementary Fig. 9b).
According to previous reports34–36, binding of the ssDNA complementary to the crRNA activates Cas12a for nonspecific trans cleavage. We also observed that EcoCas3 and LbaCas12a were activated by crRNA-complementary ssDNA (TS) but not by non-complementary ssDNA (NTS) (Fig. 2c, d). However, the PAM specificity was different between EcoCas3 and LbaCas12a. LbaCas12a was activated by both crRNA-complementary TS flanked by a PAM (3′-AAAC-5′) or a nonPAM (3′-TTTG-5′) (Fig. 2d), as previously reported34,35. In contrast, EcoCas3 was partially activated by a TS with a PAM (3′-TTC-5′) but a TS with a nonPAM (3′-GGT-5′) prevented any activity (Fig. 2c). One potential explanation for why the PAM specificity was not observed in LbaCas12a is that the dsDNA targets are not fully double stranded, and some ssDNA contamination is sufficient to activate LbCas12a. We then tested TS PAM specificity for all 64 possible target sites (Fig. 2e). The PAM specificities for ssDNA-activated collateral cleavage were similar to those of dsDNA-activated collateral cleavage (Fig. 2a), although the activity was mostly lower for ssDNA-activated cleavages, except for when the third nucleotide of the PAM was C, such as 3′-TAC-5′, 3′-AGC-5′, 3′-GTC-5′, 3′-GAC-5′, and 3′-GGC-5′, when the relative fluorescence was increased (Fig. 2e). This means the third nucleotide of the TS PAM is important for the collateral cleavage.
Base-pairing between the TS and NTS of the PAM leads to correct Cascade/crRNA binding of the NTS, accessibility of the EcoCas3 cleavage site, and degradation of the target DNA24,49. We observed that dsDNA containing an unpaired PAM between NTS-nonPAM (5′-CCA-3′) and TS-PAM (3′-TTC-5′) partially activated EcoCas3 for collateral ssDNA cleavage (Supplementary Fig. 10a). This is in contrast to previous reports of dsDNA with an unpaired PAM not showing any activity for target dsDNA degradation24,49. Screening of PAM base-pairing between each of the three nucleotides showed that base-pairing of the third nucleotide positively affected collateral cleavage activity, and that base-pairing of the first and second nucleotides additively increased the activity of the third nucleotide base-pairing (Supplementary Fig. 10b). Interestingly, the crRNA-complementary ssDNA, where the PAM region was double stranded but the rest of the protospacer was single stranded, displayed higher activity than either ssDNA- or dsDNA-activated collateral cleavage (Fig. 2f). This is probably because the protospacer ssDNA can easily bind to the complementary crRNA without unwinding the target dsDNA, which is followed by Cas3 recruitment and activation for ssDNA cleavage. Together, these results of PAM recognition specificity are mostly consistent with results from in vitro reconstitution24,49 and of crystal structure analysis18, except for the partial activity detected for collateral cleavage, in contrast to no activity for target DNA degradation by unpaired PAM recognition24.
EcoCas3 cleaves the NTS in cis followed by the TS in trans in a helicase-dependent manner
Complete R-loop formation by the Cascade/crRNA complex recruits the Cas3 helicase/nuclease, which repeatedly cleaves the NTS via the HD domain’s single catalytic site32,33. It remains unknown how EcoCas3 cleaves the TS and progressively degrades the dsDNA substrate (Fig. 1a). Considering the collateral non-specific ssDNA cleavage in trans, we hypothesized that the TS can be cleaved in trans, following cis cleavage of the NTS after target dsDNA unwinding by the helicase properties of Cas3. To test this, we designed fluorescently labeled target dsDNA substrates, 5′-NTS-FAM, and 5′-TS-TAMRA, to visualize dsDNA cleavage by EcoCas3 (Supplementary Fig. 11a). In control experiments, SpCas9 cleaved both NTS and TS at 3–4 nucleotides upstream of the PAM site, as expected (Fig. 3a). In contrast, the highest peak of EcoCas3 cleavage was 10–11 nucleotides downstream of the PAM site on the NTS, while several peaks upstream of the PAM site demonstrated repetitive cleavage of the NTS. We also observed repetitive cleavage of dozens of nucleotides upstream of the TS PAM, which was likely reeled by EcoCas3 helicase activity and cleaved by its trans cleavage activity (Fig. 3a).
To confirm the NTS and TS cleavages mediated by nuclease/helicase activities of EcoCas3, we tested a dnCas3 HD domain mutant and a dhCas3 SF2 domain mutant in the dsDNA cleavage assay (Fig. 3b). The dnCas3 mutant cleaved neither NTS nor TS, indicating that the single catalytic domain of EcoCas3 plays a role in generating double-strand breaks (DSBs). Notably, the dhCas3 mutant cleaved the NTS, but not the TS, indicating that the dhCas3 mutant (S483A/T485A) works as an EcoCas3 Nickase (Fig. 3b). In ATP-free reaction buffer, the wild-type EcoCas3 and the dhCas3 mutant also cleaved the NTS, but not the TS (Fig. 3c and Supplementary Fig. 11b). Given the assay’s collateral cleavage results, where the dhCas3 mutant cleaved non-specific ssDNA (Fig. 1f), the helicase activity of EcoCas3 followed by reeling of TS is indispensable not only for repetitive cis cleavage of the NTS but also for trans cleavage of the reeled TS.
To further characterize cis and trans cleavage by EcoCas3, we compared 30 s (short) and 5 min (long) incubation times for the dsDNA cleavage assay. More prolonged incubation increased repetitive cleavage of the NTS in cis and the TS in trans (Supplementary Fig. 12a). We also observed that progressive cis and trans cleavages showed similar patterns in the repetitive experiments and the short and long incubation experiments, depending on the target DNA sequence, e.g., hEMX1 and mTyr (Supplementary Fig. 12a). The sizes of many cleaved fragments were between 30 and 60 bps, which may be used for CRISPR adaptations as previously reported12,50 (Supplementary Fig. 12b).
Incomplete binding of EcoCascade to target DNA with tolerated mismatches elicits collateral ssDNA cleavage but not target dsDNA degradation
We previously reported that a single mismatch within the seed region markedly affected target DNA degradation in the EcoCascade/Cas3 system11. We, therefore, investigated the effect of mismatch for each nucleotide in the 32-nt spacer on collateral ssDNA cleavage activity. A single mismatch in the spacer region, even within the seed region (positions 1–8), resulted in little or no effect on collateral cleavage activity (Supplementary Fig. 13a, b). In the LbaCas12a system, 1–3 mismatches in the seed region also did not affect collateral cleavage activity (Supplementary Fig. 13c), consistent with previous reports36,51. Previous in vitro analysis revealed the effect of single mismatches in the target sequence, which slow the rate of R-loop formation and target-strand cleavage by Cas12a52,53. To investigate whether Cascade-binding and R-loop-formation are linked with collateral cleavage and target DNA degradation, we sought to characterize Cascade-target DNA binding kinetics using a Bio-layer interferometry (BLI) biosensor54. Corresponding to the collateral cleavage assay results (Fig. 2c), crRNA-complementary TS-ssDNA showed associations with EcoCascade but not with non-complementary NTS-ssDNA (Supplementary Fig. 14a and Supplementary Table 1). Notably, the crRNA-complementary TS-PAM (3′-TTC-5′) showed higher association than that of TS-nonPAM (3′-GGT-5′) or -PAMless (Supplementary Fig. 14a). Moreover, dsDNAs containing a paired PAM (5′-AAG-3′ − 3′-TTC-5′) showed the maximum EcoCascade-target DNA binding (Supplementary Fig. 14b and Supplementary Table 1), which corresponds to the results of the collateral cleavage assay (Fig. 2f). Unpaired PAM between TS-PAM (3′-TTC-5′) and NTS-nonPAM (5′-CCA-3′) indicated a lower association, and unpaired PAM between NTS-PAM (5′-AAG-3′) and TS-nonPAM (3′-GGT-5′) showed little association (Supplementary Fig. 14b). Taken together, BLI can provide solid information on the affinity and stability of interactions as previously reported54.
To further investigate the relationship between the R-loop-formation and EcoCas3-mediated collateral ssDNA cleavage and dsDNA degradation, we assayed different length R-loop formations, from 0 to 32 nucleotides (n0, n6, n12, n18, n24, n30, and n32) (Fig. 3d). BLI revealed that crRNA-DNA hybridization with 0–12 base-pairs (n0, n6, and n12) including seed sequences did not show any association, while 18–30 base-pairs (n18, n24, and n30) produced a degree of association. Furthermore, a complete match for 32 base-pairs (n32) resulted in stable and emphatic Cascade binding, similar to locked R-loop formation reported previously15,19,29 (Fig. 3e and Supplementary Table 1). In the collateral cleavage assay, n0, n6, and n12 did not show any cleavage activity, while n18–n32 R-loop formations increasingly promoted trans cleavage of ssDNA (Fig. 3f). In the dsDNA cleavage assay, n0–n24 did not show any cleavage of either NTS or TS DNA (Fig. 3g). This means that collateral cleavage does not need the nicking activity on the NTS (n18 and n24). Only the n30 and n32 sequences underwent repetitive cleavage on both the NTS and TS, and progressive cleavage of target dsDNA substrates (Fig. 3g). Taken together, these results show two Cascade binding modes. Intermediate R-loop formation by mismatches on the spacer sequences elicits collateral ssDNA cleavage. Complete R-loop formation with full crRNA-DNA hybridization leads to repetitive cis cleavage of the NTS with trans cleavage of the TS to degrade the target dsDNA substrate, as described in previous reports15,19,29.
Dynamic visualization of CRISPR interference: PAM search, nicking, and DSB
Cryo-EM and smFRET are not capable of visualizing how EcoCas3 degrades target dsDNA12,31 (Fig. 1a). We therefore employed hs-AFM, which enables real-space and real-time observations of CRISPR-Cas3 reacting with target DNAs at the macromolecule level, as previously shown by visualizing CRISPR-Cas9 interference55. First, we visualized the binding of Cascade/crRNA to a target DNA, a 645 bp dsDNA containing a target spacer site flanked by a PAM (5′-AAG-3′) at 219 and 423 bp from the ends of the DNA fragment (Fig. 4a). We adsorbed the mixture of donor DNAs and EcoCascade RNPs onto a 3-aminopropyltrietoxysilane-mica surface (APTES-mica)56. As expected, hs-AFM demonstrated that EcoCascade RNP specifically bound to the expected target site in the dsDNA (Supplementary Fig. 15a–d). Notably, we frequently observed a typical DNA bend at the EcoCascade-RNP binding site (Fig. 4b). The DNA angle distribution around the bound EcoCascade RNP exhibited a large spread with a peak near 45°, while the DNA angle distribution around bare DNA showed an intrinsic gradual curve reflecting the persistence length of dsDNA, with or without Cas357,58 (Fig. 4c, d and Supplementary Fig. 15e, f). This DNA bending by a Cascade for stable R-loop formation was previously indicated by cryo-EM15,18 and smFRET studies16,59. During the observation periods, the EcoCascade RNPs bound tightly to the target DNAs without dissociating, consistent with previous smFRET analyses16,20,59.
We also observed target interrogation by the EcoCascade RNP on a mica-supported lipid bilayer (mica-SLB), which was indispensable to observe the dynamic events of EcoCascade RNPs, as previously used in the CRISPR-Cas9 system55. While the Cascades bound to the target site for more than 10 s in all cases, the duration of the non-target Cascade was mostly measured to be less than 1 s (Supplementary Fig. 16). We sometimes observed that the EcoCascade RNP ran from one end to the other through the target DNA (Fig. 4a, b and Videos 1 and 2), presumably searching for the right PAM site and spacer sequences, as shown by the smFRET studies16,59.
Next, we injected EcoCas3 proteins after immobilizing the EcoCascade RNPs with the 645-bp target DNA in ATP-free reaction buffer on the mica-SLB to reproduce EcoCas3-mediated nicking at the target site. In this preparation, several single-strand break (SSB)-like DNAs at the Cascade binding site were observed (Fig. 4e and Video 3). We measured the DNA height because the preliminary experiments revealed a decrease in height at the nick site in artificially nicked DNA using Nb.BsrDI nicking endonucleases on APTES mica (Supplementary Fig. 17). Therefore, we observed pre-mixed EcoCas3-EcoCascade-dsDNA on APTES mica and measured the height of DNA for a more quantitative analysis. When removing the protein complex from dsDNA by applying extensive force, we observed a nick-like shape, where the DNA chain remained connected, but the height of dsDNA appeared to be partially lower in ∼60% of the complex (Supplementary Fig. 18a, b and Videos 3 and 4). In contrast, no nick structure was observed after mechanically removing EcoCascade from dsDNA without EcoCas3 protein (Supplementary Fig. 18c–e). These observations, therefore, demonstrate that EcoCas3 induces the nick as depicted in the in vitro experiments in Fig. 3.
In contrast, in ATP-containing reaction buffer, we detected many short DNA fragments after injection of EcoCas3 proteins (Supplementary Fig. 19). The DNA fragment lengths obtained varied widely but were commonly approximately 200 bps. Notably, we observed the EcoCas3-Cascade complex bound to the target site was repeatedly reeling the longer side of the DNA then releasing it, as previously reported20 (Fig. 5a, b, Supplementary Fig. 20 and Videos 5–7). Finally, we captured the dynamic movements by which the EcoCas3-Cascade complex shortened the target DNA and cleaved it with a DSB after the reeling reaction, followed by release of the DNA from the EcoCas3-Cascade complex (Fig. 5b and Videos 6 and 7). These results clearly indicated that the DNA fragments can be cleaved upstream of the target site when they are shortened by reeling, rather than by Cas3 translocation.
Discussion
Up until now, it has been unclear how a single HD nuclease domain in Cas3 can cause DSBs at target sites and long-range unidirectional deletions upstream of target sites10,11,13,15,26,30,31. We believe that this is the first report to use hs-AFM to capture the dynamic movements of CRISPR-Cas3 interference at the single molecule level. The hs-AFM results clarify that the EcoCascade/crRNA complex searches for and binds to target DNA, and recruited EcoCas3 bound to EcoCascade then reels and loops the target dsDNA, and subsequently cleaves it (Fig. 6). This is consistent with a reeling model in which Cas3 remains associated with Cascade to cleave ssDNA by a reeling mechanism12. However, it remained unknown how EcoCas3 cleaves the reeled TS and progressively degrades the dsDNA substrate (Fig. 1a). Our results from collateral ssDNA cleavage assays and dsDNA cleavage assays revealed that Cas3 repeatedly cleaves the NTS by helicase activity in cis. Simultaneously, the TS reeled by the helicase property of Cas3 can be cleaved by non-specific ssDNA cleavage activity in trans. The hs-AFM analysis also revealed that Cascade-bound Cas3 repeatedly reels and releases the target DNA upstream of the PAM site, followed by target degradation. (Supplementary Fig. 14). Although these results are inconsistent with a translocation model (Fig. 1a), Cas3 with Cas1 and Cas2 forming a primed acquisition complex may translocate in search of protospacers20,60. Despite hs-AFM being able to analyze regions of hundreds of bp, it is not feasible to visualize long-range dsDNA cleavages (in the order of kb) in vitro. Previous in vivo experiments with the CRISPR-Cas3 system10,11 indicated unidirectional long-range deletions, where the spacer sequences and the PAM site remained in the absence of indel mutations and repetitive fragmented DNA deletions upstream of the PAM sites. The hs-AFM movement capture results support this CRISPR interference phenomenon, where the EcoCascade/Cas3 complex remains bound to the target site to repeat DNA degradation, which may expand the deletion size.
Previous studies revealed that type I CRISPR systems have two binding modes for target recognition called interference and priming19,20,59,61 (Fig. 6). The low fidelity priming mode allows a whole range of mutated invaders to be detected and the priming process to be initiated19,36,51,59,62,63. Meanwhile, the high-fidelity interference mode ensures the destruction of perfectly matching targets to destroy foreign invaders without new spacer acquisition. Our results using the BLI biosensor show that partial R-loop formation (18–24 bp) enforces short-lived and unstable Cascade binding, whereas full R-loop formation (30 and 32 bp) provides locked and immobilized Cascade binding to the target DNA (Fig. 3e). We also find that this partial Cascade binding can recruit Cas3 to mediate non-specific ssDNA cleavage in trans, but can also interrupt dsDNA cleavage in cis (Fig. 3f, g). Moreover, this collateral ssDNA cleavage tolerates mismatches within the spacer sequences (Supplementary Fig. 11a, b), in contrast to our previous findings with target dsDNA cleavage11. These findings suggest that the type I CRISPR system uses the collateral ssDNA cleavage for the priming process (Fig. 6). This is also supported by recently reported results showing that Cas12a has multiple nicking activities with tolerance of 4–8 mismatches within the PAM and spacer sequences in a natural role as an immune effector against rapidly evolving phages36,51.
Our results also indicate that only stable Cascade binding can initiate nicking of the NTS and activate the ATP-dependent helicase property of Cas3, which reels and loops the TS for cleavage in the interference mode15,19,29 (Fig. 6). It is still unclear what the critical step is that drives the Type I CRISPR interference mode. Previous cryo-EM studies reveal that full R-loop formation following conformational changes of Cascade triggers a flexible bulge in the NTS, enabling Cas3 nicking in this region15,31. In addition, the trans cleavage activities can be controlled by multiple steps including specific PAM recognition, R-loop formation-dependent conformational changes in Cascade, and recruitment of Cas3 and conformational changes in Cas3 itself, as previously suggested by several crystal structure or cryo-EM studies15,17,18,21,22,27,64. Importantly, Cas8 adopts a different conformation when bound to ssDNA for controlling Cas3 recruitment and activity, which correlates with the attenuation of interference and relative increase in priming activity upon target mutation24,61. Crystal structure65 and cryo-EM31 analysis also showed that Cas3 recruited to Cascade may be activated by guiding ssDNA to the HD domain by either of two routes, the bypass route or the helicase tunnel. Considering our findings and structural data31,65, EcoCas3 may continuously cleave NTS via the helicase tunnel. Simultaneously, EcoCas3 cleaves the TS by collateral trans cleavage activity through the bypass route. By repeating cis NTS cleavage via the helicase tunnel route and trans TS cleavage via the bypass route, EcoCas3 may achieve phage plasmid degradation in E. coli8 and large-scale genome editing in human cells10,11 (Fig. 6).
The CRISPR-Cas3 system in the host bacteria potently degrades phage and viral DNA. If Cas3 is too powerful, it may have the potential for self-attack, from which the host must escape. EcoCas3 has a longer spacer sequence of 27 nucleotides compared with the 20 nucleotides of Cas9 or the 24 nucleotides of Cas12, which may increase the specificity for target recognition. EcoCas3 has maximal cleavage activity at 37 °C, although EcoCas3 protein is sensitive to temperature-dependent aggregation at 37 °C (Supplementary Fig. 3), which may also decrease self-attack. The specific PAM recognition by EcoCascade can also enable escape from self-attack (Fig. 2) because various CRISPR-Cas systems have a PAM system that distinguishes self from non-self28. Crystal structure analysis showed that Cas9 and Cas12 enable R-loop formation by first recognizing and unwinding the NTS-PAM28. Compared with Cas9, Cas12a loosely fits the PAM binding channel, allowing it to slightly open during suboptimal PAM binding66. The resulting loss of specific interactions between the PAM and the Cas12a channel can explain the observed higher trans cleavage activities of Cas12a66. In the CRISPR-Cas3 system, EcoCas3 recruitment and binding to EcoCas8 depend on TS-PAM recognition. EcoCas8 binds to the third position of the TS-PAM and unwinds through recognition of the NTS-PAM18, which may increase PAM specificity in collateral ssDNA cleavage (Fig. 2). Our experiments with the ssDNA where the PAM region was double stranded, but the rest of the protospacer was single stranded (Fig. 2f), suggested the proper Cas8 conformation with a double-stranded PAM allowing Cas3 recruitment, which may enable the partial ssDNA to fully activate trans cleavage. In the CRISPR-Cas3 system, the PAM plays an important role in self- and non-self-discrimination, and PAM recognition by Cas effectors is the initial step following the formation of an R-loop structure with the crRNA18,28.
In conclusion, we found that the partial binding of EcoCascade to target DNA can elicit collateral non-specific ssDNA cleavage in the priming mode. With stable binding by a complete R-loop formation, the collateral ssDNA cleavage can be used for trans cleavage of the TS combined with repetitive cis cleavage of the NTS to degrade the target dsDNA substrate in the interference mode. These results provide a mechanistic insight into collateral ssDNA cleavage and target DNA cleavage by the CRISPR-Cas3 system, enabling further understanding of type I CRISPR priming and interference of foreign DNAs.
Methods
Expression and purification of EcoCas3 and EcoCascade/crRNA
We employed a method to express recombinant EcoCas3 at a low temperature using a baculovirus expression system. Briefly, we cloned an EcoCas3 cDNA with a octa-histidine tag and a six asparagine-histidine repeat tag into a pFastbac-1 plasmid (Thermo Fisher Scientific, Waltham, Massachusetts, USA) according to the manufacturer’s instructions (Supplementary Fig. 2a). The TEV protease recognition site was also inserted between the tags and EcoCas3 to enable tag removal. Self-ligation of the PCR product generated the mutant Cas3, such as H74A (dead nickase; dn) and S483A and T485A double mutant (dead helicase; dh) with PrimeSTAR MAX (Takara Bio, Kyoto, Japan). Coding sequences cloned in the plasmids are listed in Supplementary Data 1.
Expression of EcoCas3-tag fusion proteins in Sf9 cells. We infected Sf9 cells with baculovirus at a multiplicity of infection (MOI) of two at 28 °C for 24 h. Then, we changed the culture temperature to 20 °C four days after infection for protein expression. Sf9 cells were then collected and stored at −80 °C until use. The expressed EcoCas3-tag fusion proteins were purified using nickel affinity resin (Ni-NTA, Qiagen, Hilden, Düsseldorf, Germany). To remove tags, purified protein was digested with TEV protease and then further purified by size-exclusion chromatography using Superdex 200 Increase 10/300 GL (Thermo Fisher Scientific) in 0.2 M NaCl, 10% glycerol, 1 mM DTT, and 20 mM HEPES-Na (pH 7.0).
Cascade from E. coli and CRISPR RNA complex (EcoCascade/crRNA) was produced as described previously24,41. Briefly, we cloned EcoCas11 with a hexahistidine tag and HRV3C protease recognition site, EcoCascade operon, and pre-crRNA into pCDFDuet-1, pRSFDuet-1, and pACYCDuet-1 plasmids, respectively (Supplementary Fig. 2c). Sequences cloned in these plasmids are also listed in Supplementary Data 1. Then, we transformed JM109(DE3) with three plasmids to express EcoCascade/crRNA recombinant protein complex. Expressed recombinant EcoCascade-crRNA was purified using Ni-NTA resin. After removal of the hexahistidine tag by HRV3C protease, EcoCascade-crRNA was further purified by size-exclusion chromatography in 350 mM NaCl, 1 mM DTT, and 20 mM HEPES-Na (pH 7.0).
Thermal stability assay of EcoCas3
Thermal stability was evaluated by nanoDSF using the Tycho NT.6 system (NanoTemper Technologies GmbH, München, Germany)67. Also, Thermal stability at a constant 37 °C was measured by a thermal shift assay using a Mx3000p real-time PCR instrument (Agilent technologies, Santa Clara, California, USA) and SYPRO orange (Thermo Fisher Scientific)68.
Single and double-stranded DNA preparation
To detect in vitro DNA cleavage activity of CRISPR-Cas3 proteins, targeted sequences of EMX1 with PAM variants (5′-AAG-3′ or 5′-CCA-3′) were cloned into a pCR4Blunt-TOPO plasmid vector (Thermo Fisher Scientific) according to the manufacturer’s protocol. For collateral DNA cleavage assays, 60 bp activator fragments of hEMX1 and mTyr (which included a target site) were designed and purchased. Targeted sequences for CRISPR-Cas3, CRISPR-Cas12a, and CRISPR-Cas9 are listed in Supplementary Data 2. PAM sequence variants and targeted sequence variants were also designed to examine collateral ssDNA cleavage activity. Biotin-labeled fragments were also purchased for protein-DNA interaction analysis. For fragment analysis, fluorescence-labeled primers were designed and the DNA fragment amplified from genomic DNA of HEK293T cells using Gflex DNA polymerase (Takara-bio). Amplicons were purified using NucleoSpin Gel and a PCR Clean-up kit (Takara-bio) according to the manufacturer’s protocols. A DNA fragment for hs-AFM was also amplified with non-labeled primers. All sequences of primers and donor DNAs are listed in Supplementary Table 3 and Supplementary Data 2, respectively.
In vitro DNA cleavage activity
To analyze DNA cleavage activity, 1.6 nM of plasmid with or without targeted sequences were added to 115 nM EcoCascade-crRNA complex, 250 nM EcoCas3, and 2.5 mM ATP in CRISPR-Cas3 working buffer (60 mM KCl, 10 mM MgCl2, 10 µM CoCl2, 5 mM HEPES-KOH, pH 7.5), as previously described34,43,47. After incubation at 37 °C, samples were detected by either electrophoresis or with the MultiNa microchip electrophoresis system and the DNA-12,000 kit (Shimadzu, Kyoto, Japan).
Reporter assay for DNA and RNA cleavage
To characterize Cas3 collateral nucleic acid cleavage activities, 50 nM DNA activator templates were added to 100 nM EcoCascade-crRNA complex, 250 nM EcoCas3 and 2.5 mM ATP in CRISPR-Cas3 working buffer (60 mM KCl, 10 mM MgCl2, 10 µM CoCl2, 5 mM HEPES-KOH, pH 7.5). We used the DNase Alert kit (Integrated DNA Technologies, Coralville, IA USA) and the RNase Alert kit (Integrated DNA Technologies) for detecting DNase and RNase activity, respectively. To measure the ssDNA cleavage activity, we used the qPCR reporter probe for GAPDH (the sequence is listed in Supplementary Table 3) at 125 nM. Cleavage-related change in fluorescence signal of the probe was measured every 30 s for 60 min under incubation at 37 °C using a Real-time PCR system (Bio-Rad Laboratories, Hercules, California, USA). Alternatively, M13mp18 single-stranded DNA (New England Biolabs, Ipswich, Massachusetts, USA) or pBluescript plasmid were added and incubated at 37 °C. Samples were then electrophoresed on an agarose gel.
DNA fragment analysis
To analyze CRISPR DNA cleavage patterns in vitro, 16 nM DNA fragments amplified from HEK293 genomic DNA were added to 160 nM EcoCascade-crRNA complex, 400 nM EcoCas3 and 2 mM ATP in CRISPR-Cas3 working buffer (60 mM KCl, 10 mM MgCl2, 10 µM CoCl2, 5 mM HEPES-KOH pH 7.5). After incubation at 37 °C, DNA samples were purified by ethanol precipitation. The length of DNA in samples was measured using GeneScan 600 LIZ dye Size Standard (Thermo Fisher Scientific) via a G5 dye set filter. All data were analyzed using PeakScanner software (Thermo Fisher Scientific).
Protein-DNA interaction assay
The evaluation of binding properties between EMX-EcoCascade (analyte) and target DNAs (ligands) was performed by BLI using the Octet RED 96 system (ForteBio, Sartorius BioAnalytical Instruments, Fremont, California, USA). All ligands were biotinylated (20 µM) and immobilized on streptavidin biosensors. Kinetic titration series were performed in interaction buffer (PBS with 0.01% Tween 20, 0.02% BSA). Analyte concentration was 20 µM in the interaction buffer. The association and dissociation times were both 300 s to measure the interaction between ligands and analyte. These raw data were analyzed using ForteBio analysis software. The binding sensorgram was locally fitted to a 1:1 Langmuir binding model with mass transport limitation. Sequences for the donor DNA fragments were listed in Supplementary Data 2.
High-speed atomic force microscopy (hs-AFM) setup
hs-AFM imaging was performed in solution using a laboratory-built hs-AFM setup as described previously55. We used small cantilevers (BLAC10DS-A2, Olympus, Tokyo, Japan) with a nominal spring constant of 0.1 N/m, resonance frequency of ∼0.5 MHz, and a quality factor of ∼1.5 in the buffer. The probe tip was grown on the original tip of a cantilever through electron beam deposition using ferrocene and was further sharpened using a radio-frequency plasma etcher (Tergeo, PIE Scientific LLC, USA) under an argon gas atmosphere (Direct mode, 10 sccm, and 20 W for 1.5 min). A glass sample stage (diameter, 2 mm; height, 2 mm, Japan Cell, Tokyo, Japan) with a thin mica disc (1.5 mm in diameter and ∼0.05 mm thick, Furuuchi Chemical Corporation, Tokyo, Japan) glued to the top by epoxy was attached the top of a Z-scanner with a drop of nail polish.
Engagement of the probe with the surface before scanning was performed using a stepping motor55. The speed of engagement was ∼0.7 μm/s when the distance between the probe and surface was more than 10 μm. After that, the speed was slowed to ∼0.3 μm/s. During engagement, the feedback control for the cantilever’s oscillation amplitude was applied with a moderate feedback gain, in which the cantilever’s free oscillation amplitude, A0, and setpoint amplitude, Asp, were set at ∼2 nm and ∼0.95 × A0, respectively. This setting was important to avoid the probe from making a strong contact with the surface. After engagement, A0 and Asp were set at 1−2 nm and ∼0.9 × A0, respectively. While taking AFM images, the feedback gain, mainly the integral gain and supportively the proportional gain, was adjusted until clear images appeared. When a strong tapping force was required, Asp was lowered to ∼0.3 × A0.
Observation by hs-AFM
To observe the reaction intermediates of EcoCascade/crRNA and dsDNA before and after addition of EcoCas3 and/or ATP at high spatial resolution, we used 3-aminopropyltriethoxysilane treated mica (APTES-mica) as described previously55. The premix complex of EcoCascade/crRNA and dsDNA was prepared in observation buffer (5 mM HEPES-KOH, pH 7.5, 30 mM KCl, 1 mM MgCl2, 2 μM CoCl2, 10% glycerol) at room temperature (∼25 °C) using 1.5 nM EcoCascase/crRNA and 0.5 nM dsDNA. The premix complex of EcoCascade/crRNA, dsDNA and EcoCas3 was prepared in observation buffer using 75 nM EcoCascade/crRNA, 25 nM dsDNA, and 150 nM EcoCas3, and incubated at 37 °C for 30 min, after which the solution was diluted 50 times with observation buffer. The reaction intermediates of EcoCascade/crRNA and dsDNA after the addition of EcoCas3 and ATP were prepared in observation buffer using 75 nM EcoCascade/crRNA, 25 nM dsDNA, 150 nM EcoCas3 and 1 mM ATP, and incubated at 37 °C for 5 min, after which the solution was immediately placed on ice to stop the reaction. Just before use, the solution of the reaction intermediates was diluted 50 times with observation buffer. The artificially nicked dsDNA was diluted to 1 nM with Milli-Q water. A drop (2 μl) of either sample solution was deposited on the APTES-mica. Three minutes later the sample surface was rinsed with 20 μl observation buffer. We then immersed the sample stage in a liquid cell containing about 60 μl observation buffer69,70, and hs-AFM imaging was performed at room temperature (∼25 °C). The addition of 10% glycerol in the buffers helped to prevent deterioration of the probe tip, but not completely.
To observe dynamic behaviors of EcoCascade and EcoCas3 on dsDNA, we used a mica-supported lipid bilayer (mica-SLB) as a sample substrate55,69,71. To observe EcoCascade binding to a target site, a lipid composition of 90:5:5 (w/w) DPPC:DPTAP:biotin-cap-DPPE was used. The liposome solution dissolved in Milli-Q water at 2 mg/ml was prepared as described previously55 and stored as 50 μl aliquots at −20 °C before use. After thawing an aliquot, the liposome solution was diluted with the equivalent volume of 10 mM MgCl2 and sonicated with a bath sonicator (AUC-06L, AS-One, Osaka, Japan) to obtain small unilamellar vesicles. A drop (2 μl) of the sonicated liposome solution was deposited on the surface of freshly cleaved mica for more than 5 min at room temperature (24–26 °C), during which the stage was covered with a humid cap to avoid surface drying. The sonicated liposome solution could be stored at −20 °C and used repeatedly by applying the sonication. Before deposition of the samples, the surface of the sample stage was rinsed with a large amount of Milli-Q water (∼20 µl × five times) to remove excess liposomes and lipid bilayers. We deposited 2 μl dsDNA amplicon diluted to 5 nM with Milli-Q water on the mica-SLB. Three minutes later the sample surface was rinsed with 20 μl observation buffer to remove the unattached dsDNA. We then immersed the sample stage in a liquid cell containing about 60 μl observation buffer, and hs-AFM imaging was performed in a room heated to 30 °C. We added a drop (∼6 μl) of EcoCascade diluted with observation buffer, which was equilibrated to ∼30 °C, to the liquid cell during the hs-AFM observations, resulting in a final concentration of ∼20 nM.
To observe DNA reeling and DSB generation by EcoCas3, the lipid composition used was 80:10:10 (w/w) DPPC:DPTAP:biotin-cap-DPPE. Increasing the ratio of biotin-cap-DPPE improved the efficiency of the reeling and the DSB reaction induced by EcoCas3. A drop (2 μl) of EcoCascade-DNA pre-assembled with 20 nM EcoCascade in observation buffer was placed on the mica-SLB together with 2 nM DNA at 37 °C for 5 min. The sample surface was rinsed with 20 μl observation buffer and then imaged with hs-AFM, with a head temperature controlled at ∼37 °C, which is a suitable temperature for DSBs, using a thermostatic cover. During the hs-AFM observations, a drop (∼6 μl) of EcoCas3 and ATP mixture diluted with observation buffer to a final concentration of ∼100 nM and ∼2 mM, respectively, was equilibrated to ∼37 °C and added to the liquid cell.
Under the above observation conditions, at least one target molecule (i.e., the complex of EcoCascade/crRNA and dsDNA with or without EcoCas3, with dsDNA generated by the DSBs reaction or artificially nicked dsDNA) was observed in an observation area of 500 × 500 nm2, such that the target molecule can be easily encountered. The reproducibility of the AFM observations was confirmed by performing at least three independent experiments. As DPTAP has a positively charged head group, addition of DPTAP facilitated immobilization of negatively charged DNA on mica-SLB. As biotin-cap-DPPE has a bulky head group, addition of biotin-cap-DPPE induced sub-nanometer roughness on mica-SLB. This increased the mobility of dsDNA on the surface and sometimes allowed the observation of binding events of proteins that surround dsDNA as previously seen for CRISPR-Cas955. Primers for the donor DNA amplicons are listed in Supplementary Table 3.
Reporting summary
Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Supplementary information
Acknowledgements
We thank T. Omoto, and S. Kobori at Osaka University, M. Hoshi, K. Mochizuki, and A. Fukui at Tokyo University, and S. Saji, S. Yamamoto, and N. Godai at the RIKEN SPring-8 Center for their technical assistance and Drs. T. Ando and T. Watanabe-Nakayama for technical support with hs-AFM. We also thank Professor Jacob Corn at ETH Zurich for scientific advice and Jeremy Allen, PhD from Edanz Group (https://en-author-services.edanz.com/ac) for editing a draft of this manuscript. This project was supported by JSPS KAKENHI Grant Number 18H03974 (T.M.), 19K16025 (K.Y.), 19KK0401 (K.Y.) and 20H00327 (N.K.), and JST-CREST (JPMJCR1762 to N.K.). Support also came from the Platform Project for Supporting Drug Discovery and Life Science Research [Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)] from AMED under Grant Number JP20am0101070 (support numbers 1251 and 2463).
Author contributions
K.Y. and S.S. designed and performed most of the experiments, analyzed the data with assistance from Y.K. and Y.Y. K.T., M.O., and M.Y. prepared and characterized the CRISPR-Cas proteins. N.K., K.U., K.Y., and K.T. performed the hs-AFM experiments. T.M. conceived and supervised the study, and wrote the manuscript with editorial contributions from all authors.
Peer review
Peer review information
Nature Communications thanks the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Peer review reports are available.
Data availability
The data that support this study are available from the corresponding author upon reasonable request. Source data are provided with this paper.
Competing interests
S.S. and Y.K. are employees of C4U Corporation. K.Y., K.T., and T.M. are scientific advisors to C4U Corporation, which does not affect any result and conclusion reported in the paper. The other authors declare no competing interests.
Footnotes
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
These authors contributed equally: Kazuto Yoshimi, Kohei Takeshita, Noriyuki Kodera.
Supplementary information
The online version contains supplementary material available at 10.1038/s41467-022-32618-0.
References
- 1.Makarova KS, et al. Evolutionary classification of CRISPR-Cas systems: A burst of class 2 and derived variants. Nat. Rev. Microbiol. 2020;18:67–83. doi: 10.1038/s41579-019-0299-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Pickar-Oliver A, Gersbach CA. The next generation of CRISPR-Cas technologies and applications. Nat. Rev. Mol. Cell Biol. 2019;20:490–507. doi: 10.1038/s41580-019-0131-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Knott GJ, Doudna JA. CRISPR-Cas guides the future of genetic engineering. Science. 2018;361:866–869. doi: 10.1126/science.aat5011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Murugan K, Babu K, Sundaresan R, Rajan R, Sashital DG. The revolution continues: Newly discovered systems expand the CRISPR-Cas toolkit. Mol. Cell. 2017;68:15–25. doi: 10.1016/j.molcel.2017.09.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Harrington LB, et al. Programmed DNA destruction by miniature CRISPR-Cas14 enzymes. Science. 2018;362:839–842. doi: 10.1126/science.aav4294. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Karvelis T, et al. PAM recognition by miniature CRISPR-Cas12f nucleases triggers programmable double-stranded DNA target cleavage. Nucleic Acids Res. 2020;48:5016–5023. doi: 10.1093/nar/gkaa208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Luo ML, Mullis AS, Leenay RT, Beisel CL. Repurposing endogenous type I CRISPR-Cas systems for programmable gene repression. Nucleic Acids Res. 2015;43:674–681. doi: 10.1093/nar/gku971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Hidalgo-Cantabrana C, Goh YJ, Pan M, Sanozky-Dawes R, Barrangou R. Genome editing using the endogenous type I CRISPR-Cas system in <em>Lactobacillus crispatus</em>. Proc. Natl Acad. Sci. USA. 2019;116:15774–15783. doi: 10.1073/pnas.1905421116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Pickar-Oliver A, et al. Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells. Nat. Biotechnol. 2019;37:1493–1501. doi: 10.1038/s41587-019-0235-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Dolan AE, et al. Introducing a spectrum of long-range genomic deletions in human embryonic stem cells using type I CRISPR-Cas. Mol. Cell. 2019;74:936–950.e935. doi: 10.1016/j.molcel.2019.03.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Morisaka H, et al. CRISPR-Cas3 induces broad and unidirectional genome editing in human cells. Nat. Commun. 2019;10:5302. doi: 10.1038/s41467-019-13226-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Loeff L, Brouns SJJ, Joo C. Repetitive DNA reeling by the Cascade-Cas3 complex in nucleotide unwinding steps. Mol. Cell. 2018;70:385–394.e383. doi: 10.1016/j.molcel.2018.03.031. [DOI] [PubMed] [Google Scholar]
- 13.van Erp PBG, et al. Conformational dynamics of DNA binding and Cas3 recruitment by the CRISPR RNA-guided cascade complex. ACS Chem. Biol. 2018;13:481–490. doi: 10.1021/acschembio.7b00649. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Guo TW, et al. Cryo-EM structures reveal mechanism and inhibition of DNA targeting by a CRISPR-Cas surveillance complex. Cell. 2017;171:414–426.e412. doi: 10.1016/j.cell.2017.09.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Xiao Y, et al. Structure basis for directional R-loop formation and substrate handover mechanisms in type I CRISPR-Cas system. Cell. 2017;170:48–60 e11. doi: 10.1016/j.cell.2017.06.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Xue C, Zhu Y, Zhang X, Shin YK, Sashital DG. Real-time observation of target search by the CRISPR surveillance complex cascade. Cell Rep. 2017;21:3717–3727. doi: 10.1016/j.celrep.2017.11.110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Chowdhury S, et al. Structure reveals mechanisms of viral suppressors that intercept a CRISPR RNA-guided surveillance complex. Cell. 2017;169:47–57.e11. doi: 10.1016/j.cell.2017.03.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Hayes RP, et al. Structural basis for promiscuous PAM recognition in type I-E Cascade from E. coli. Nature. 2016;530:499–503. doi: 10.1038/nature16995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Rutkauskas M, et al. Directional R-Loop formation by the CRISPR-Cas surveillance complex cascade provides efficient off-target site rejection. Cell Rep. 2015;10:1534–1543. doi: 10.1016/j.celrep.2015.01.067. [DOI] [PubMed] [Google Scholar]
- 20.Redding S, et al. Surveillance and processing of foreign DNA by the Escherichia coli CRISPR-Cas system. Cell. 2015;163:854–865. doi: 10.1016/j.cell.2015.10.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Jackson RN, et al. Structural biology. Crystal structure of the CRISPR RNA-guided surveillance complex from Escherichia coli. Science. 2014;345:1473–1479. doi: 10.1126/science.1256328. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Mulepati S, Heroux A, Bailey S. Structural biology. Crystal structure of a CRISPR RNA-guided surveillance complex bound to a ssDNA target. Science. 2014;345:1479–1484. doi: 10.1126/science.1256996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Zhao H, et al. Crystal structure of the RNA-guided immune surveillance Cascade complex in Escherichia coli. Nature. 2014;515:147–150. doi: 10.1038/nature13733. [DOI] [PubMed] [Google Scholar]
- 24.Hochstrasser ML, et al. CasA mediates Cas3-catalyzed target degradation during CRISPR RNA-guided interference. Proc. Natl Acad. Sci. USA. 2014;111:6618–6623. doi: 10.1073/pnas.1405079111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Mulepati S, Bailey S. In vitro reconstitution of an Escherichia coli RNA-guided immune system reveals unidirectional, ATP-dependent degradation of DNA target. J. Biol. Chem. 2013;288:22184–22192. doi: 10.1074/jbc.M113.472233. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Westra ER, et al. CRISPR immunity relies on the consecutive binding and degradation of negatively supercoiled invader DNA by Cascade and Cas3. Mol. Cell. 2012;46:595–605. doi: 10.1016/j.molcel.2012.03.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Wiedenheft B, et al. Structures of the RNA-guided surveillance complex from a bacterial immune system. Nature. 2011;477:486–489. doi: 10.1038/nature10402. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Gleditzsch D, et al. PAM identification by CRISPR-Cas effector complexes: Diversified mechanisms and structures. RNA Biol. 2019;16:504–517. doi: 10.1080/15476286.2018.1504546. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Songailiene I, et al. Decision-making in cascade complexes harboring crRNAs of altered length. Cell Rep. 2019;28:3157–3166.e3154. doi: 10.1016/j.celrep.2019.08.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Sinkunas T, et al. Cas3 is a single-stranded DNA nuclease and ATP-dependent helicase in the CRISPR/Cas immune system. EMBO J. 2011;30:1335–1342. doi: 10.1038/emboj.2011.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Xiao, Y., Luo, M., Dolan, A. E., Liao, M. & Ke, A. Structure basis for RNA-guided DNA degradation by Cascade and Cas3. Science361,eaat0839 (2018). [DOI] [PMC free article] [PubMed]
- 32.He, L., St John James, M., Radovcic, M., Ivancic-Bace, I. & Bolt, E. L. Cas3 protein—A review of a multi-tasking machine. Genes11, 208 (2020). [DOI] [PMC free article] [PubMed]
- 33.Liu, T. Y. & Doudna, J. A. Chemistry of class 1 CRISPR-Cas effectors: Binding, editing, and regulation. J. Biol. Chem.295, 14473–14487 (2020). [DOI] [PMC free article] [PubMed]
- 34.Chen JS, et al. CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity. Science. 2018;360:436–439. doi: 10.1126/science.aar6245. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Swarts DC, Jinek M. Mechanistic insights into the cis- and trans-acting DNase activities of Cas12a. Mol. Cell. 2019;73:589–600.e584. doi: 10.1016/j.molcel.2018.11.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Murugan K, Seetharam AS, Severin AJ, Sashital DG. CRISPR-Cas12a has widespread off-target and dsDNA-nicking effects. J. Biol. Chem. 2020;295:5538–5553. doi: 10.1074/jbc.RA120.012933. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Hidalgo-Cantabrana C, Barrangou R. Characterization and applications of type I CRISPR-Cas systems. Biochem. Soc. Trans. 2020;48:15–23. doi: 10.1042/BST20190119. [DOI] [PubMed] [Google Scholar]
- 38.Zheng Y, et al. Endogenous type I CRISPR-Cas: From foreign DNA defense to prokaryotic engineering. Front. Bioeng. Biotechnol. 2020;8:62. doi: 10.3389/fbioe.2020.00062. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Beloglazova N, et al. Structure and activity of the Cas3 HD nuclease MJ0384, an effector enzyme of the CRISPR interference. EMBO J. 2011;30:4616–4627. doi: 10.1038/emboj.2011.377. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Yosef I, Goren MG, Kiro R, Edgar R, Qimron U. High-temperature protein G is essential for activity of the Escherichia coli clustered regularly interspaced short palindromic repeats (CRISPR)/Cas system. Proc. Natl Acad. Sci. USA. 2011;108:20136–20141. doi: 10.1073/pnas.1113519108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Jore MM, et al. Structural basis for CRISPR RNA-guided DNA recognition by Cascade. Nat. Struct. Mol. Biol. 2011;18:529–536. doi: 10.1038/nsmb.2019. [DOI] [PubMed] [Google Scholar]
- 42.Mulepati S, Bailey S. Structural and biochemical analysis of nuclease domain of clustered regularly interspaced short palindromic repeat (CRISPR)-associated protein 3 (Cas3) J. Biol. Chem. 2011;286:31896–31903. doi: 10.1074/jbc.M111.270017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Gootenberg JS, et al. Nucleic acid detection with CRISPR-Cas13a/C2c2. Science. 2017;356:438–442. doi: 10.1126/science.aam9321. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Yoshimi K, et al. ssODN-mediated knock-in with CRISPR-Cas for large genomic regions in zygotes. Nat. Commun. 2016;7:10431. doi: 10.1038/ncomms10431. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Broughton JP, et al. CRISPR-Cas12-based detection of SARS-CoV-2. Nat. Biotechnol. 2020;38:870–874. doi: 10.1038/s41587-020-0513-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Patchsung, M. et al. Clinical validation of a Cas13-based assay for the detection of SARS-CoV-2 RNA. Nat. Biomed. Eng.4, 1140–1149 (2020). [DOI] [PubMed]
- 47.Yoshimi K, et al. CRISPR-Cas3-based diagnostics for SARS-CoV-2 and influenza virus. iScience. 2022;25:103830. doi: 10.1016/j.isci.2022.103830. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Fu BX, Wainberg M, Kundaje A, Fire AZ. High-throughput characterization of cascade type I-E CRISPR guide efficacy reveals unexpected PAM diversity and target sequence preferences. Genetics. 2017;206:1727–1738. doi: 10.1534/genetics.117.202580. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Westra ER, et al. Type I-E CRISPR-cas systems discriminate target from non-target DNA through base pairing-independent PAM recognition. PLoS Genet. 2013;9:e1003742. doi: 10.1371/journal.pgen.1003742. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Shiriaeva AA, et al. Detection of spacer precursors formed in vivo during primed CRISPR adaptation. Nat. Commun. 2019;10:4603. doi: 10.1038/s41467-019-12417-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Fu BXH, et al. Target-dependent nickase activities of the CRISPR-Cas nucleases Cpf1 and Cas9. Nat. Microbiol. 2019;4:888–897. doi: 10.1038/s41564-019-0382-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Singh D, et al. Real-time observation of DNA target interrogation and product release by the RNA-guided endonuclease CRISPR Cpf1 (Cas12a) Proc. Natl Acad. Sci. USA. 2018;115:5444–5449. doi: 10.1073/pnas.1718686115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Strohkendl I, Saifuddin FA, Rybarski JR, Finkelstein IJ, Russell R. Kinetic basis for DNA target specificity of CRISPR-Cas12a. Mol. Cell. 2018;71:816–824.e813. doi: 10.1016/j.molcel.2018.06.043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Muller-Esparza H, Osorio-Valeriano M, Steube N, Thanbichler M, Randau L. Bio-layer interferometry analysis of the target binding activity of CRISPR-Cas effector complexes. Front. Mol. Biosci. 2020;7:98. doi: 10.3389/fmolb.2020.00098. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Shibata M, et al. Real-space and real-time dynamics of CRISPR-Cas9 visualized by high-speed atomic force microscopy. Nat. Commun. 2017;8:1430. doi: 10.1038/s41467-017-01466-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Umemura K, Ishikawa M, Kuroda R. Controlled immobilization of DNA molecules using chemical modification of mica surfaces for atomic force microscopy: Characterization in air. Anal. Biochem. 2001;290:232–237. doi: 10.1006/abio.2001.4996. [DOI] [PubMed] [Google Scholar]
- 57.van Noort J, Verbrugge S, Goosen N, Dekker C, Dame RT. Dual architectural roles of HU: Formation of flexible hinges and rigid filaments. Proc. Natl Acad. Sci. USA. 2004;101:6969–6974. doi: 10.1073/pnas.0308230101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Rivetti C, Guthold M, Bustamante C. Scanning force microscopy of DNA deposited onto mica: Equilibration versus kinetic trapping studied by statistical polymer chain analysis. J. Mol. Biol. 1996;264:919–932. doi: 10.1006/jmbi.1996.0687. [DOI] [PubMed] [Google Scholar]
- 59.Blosser TR, et al. Two distinct DNA binding modes guide dual roles of a CRISPR-Cas protein complex. Mol. Cell. 2015;58:60–70. doi: 10.1016/j.molcel.2015.01.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Dillard KE, et al. Assembly and translocation of a CRISPR-Cas primed acquisition complex. Cell. 2018;175:934–946.e915. doi: 10.1016/j.cell.2018.09.039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Xue C, Whitis NR, Sashital DG. Conformational control of cascade interference and priming activities in CRISPR immunity. Mol. Cell. 2016;64:826–834. doi: 10.1016/j.molcel.2016.09.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Swarts DC, Mosterd C, van Passel MW, Brouns SJ. CRISPR interference directs strand specific spacer acquisition. PLoS One. 2012;7:e35888. doi: 10.1371/journal.pone.0035888. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Datsenko KA, et al. Molecular memory of prior infections activates the CRISPR/Cas adaptive bacterial immunity system. Nat. Commun. 2012;3:945. doi: 10.1038/ncomms1937. [DOI] [PubMed] [Google Scholar]
- 64.Sashital DG, Wiedenheft B, Doudna JA. Mechanism of foreign DNA selection in a bacterial adaptive immune system. Mol. Cell. 2012;46:606–615. doi: 10.1016/j.molcel.2012.03.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Huo Y, et al. Structures of CRISPR Cas3 offer mechanistic insights into Cascade-activated DNA unwinding and degradation. Nat. Struct. Mol. Biol. 2014;21:771–777. doi: 10.1038/nsmb.2875. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Yamano T, et al. Structural basis for the canonical and non-canonical PAM recognition by CRISPR-Cpf1. Mol. Cell. 2017;67:633–645.e633. doi: 10.1016/j.molcel.2017.06.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Breitsprecher D, Fung PA, Tschammer N. Improving biosensor assay development by determining sample quality with Tycho NT.6. Nat. Methods. 2018;15:298–298. doi: 10.1038/nmeth.f.406. [DOI] [Google Scholar]
- 68.Nelson R, et al. Structure of the cross-beta spine of amyloid-like fibrils. Nature. 2005;435:773–778. doi: 10.1038/nature03680. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Uchihashi T, Kodera N, Ando T. Guide to video recording of structure dynamics and dynamic processes of proteins by high-speed atomic force microscopy. Nat. Protoc. 2012;7:1193–1206. doi: 10.1038/nprot.2012.047. [DOI] [PubMed] [Google Scholar]
- 70.Nonaka S, et al. Molecular and functional analysis of pore-forming toxin monalysin from entomopathogenic bacterium pseudomonas entomophila. Front. Immunol. 2020;11:520. doi: 10.3389/fimmu.2020.00520. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Yamamoto D, et al. High-speed atomic force microscopy techniques for observing dynamic biomolecular processes. Methods Enzymol. 2010;475:541–564. doi: 10.1016/S0076-6879(10)75020-5. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The data that support this study are available from the corresponding author upon reasonable request. Source data are provided with this paper.